An exclusive distribution agreement between Medline’s Respiratory Division and Southmedic is now making it possible for clinicians to access the latest breakthrough in advanced oxygen delivery technology in the OxyMask™ portfolio. The agreement gives customers across the continuum of care even greater access to high quality products that are designed with fit, function and compliance in mind.
“As we help healthcare providers focus on clinical and financial success, we look for partners that share our vision of clinically differentiated products,” says Tim Finnigan, respiratory division president, Medline. “We’re excited to work with Southmedic to give our customers an innovative product that also enhances their patient experience.”
“Southmedic Inc. is extremely pleased with our Medline partnership because it will significantly enhance the support of customer’s OxyMask™ clinical and operational needs,” said Steve McCann, executive vice president, Southmedic. “Medline’s extensive organization and expertise across the U.S. healthcare spectrum provides a valuable conduit for a continuum of patient care for Oxymask™ and Medline complementary products.”
The OxyMask’s revolutionary open design provides a cost effective solution for patients whose oxygen requirements may vary throughout their hospital stay. It reduces the risk and dangers associated with aspiration or rebreathing CO2. Patients appreciate that it reduces feelings of claustrophobia, and families appreciate that it allows unrestricted communication. The possibility of skin breakdown is reduced because it sits lightly on the face, and it aids in the compliance of prescribed oxygen therapy by reducing interruptions.
The agreement also grants non-exclusive access to Southmedic’s OxyMask ™ EtCO2 portfolio.
For more information, please reach out to your local Medline representative, or call Medline customer service at 1-800-643-5463. Learn more about Medline respiratory solutions at www.medline.com/category/Respiratory/cat330045.